Literature DB >> 21843930

Lung deflation and oxygen pulse in COPD: results from the NETT randomized trial.

Carolyn E Come1, Miguel J Divo, Raúl San José Estépar, Frank C Sciurba, Gerard J Criner, Nathaniel Marchetti, Steven M Scharf, Zab Mosenifar, Barry J Make, Cesar A Keller, Omar A Minai, Fernando J Martinez, MeiLan K Han, John J Reilly, Bartolome R Celli, George R Washko.   

Abstract

BACKGROUND: In COPD patients, hyperinflation impairs cardiac function. We examined whether lung deflation improves oxygen pulse, a surrogate marker of stroke volume.
METHODS: In 129 NETT patients with cardiopulmonary exercise testing (CPET) and arterial blood gases (ABG substudy), hyperinflation was assessed with residual volume to total lung capacity ratio (RV/TLC), and cardiac function with oxygen pulse (O(2) pulse=VO(2)/HR) at baseline and 6 months. Medical and surgical patients were divided into "deflators" and "non-deflators" based on change in RV/TLC from baseline (∆RV/TLC). We defined deflation as the ∆RV/TLC experienced by 75% of surgical patients. We examined changes in O(2) pulse at peak and similar (iso-work) exercise. Findings were validated in 718 patients who underwent CPET without ABGs.
RESULTS: In the ABG substudy, surgical and medical deflators improved their RV/TLC and peak O(2) pulse (median ∆RV/TLC -18.0% vs. -9.3%, p=0.0003; median ∆O(2) pulse 13.6% vs. 1.8%, p=0.12). Surgical deflators also improved iso-work O(2) pulse (0.53 mL/beat, p=0.04 at 20 W). In the validation cohort, surgical deflators experienced a greater improvement in peak O(2) pulse than medical deflators (mean 18.9% vs. 1.1%). In surgical deflators improvements in O(2) pulse at rest and during unloaded pedaling (0.32 mL/beat, p<0.0001 and 0.47 mL/beat, p<0.0001, respectively) corresponded with significant reductions in HR and improvements in VO(2). On multivariate analysis, deflators were 88% more likely than non-deflators to have an improvement in O(2) pulse (OR 1.88, 95% CI 1.30-2.72, p=0.0008).
CONCLUSION: In COPD, decreased hyperinflation through lung volume reduction is associated with improved O(2) pulse.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21843930      PMCID: PMC3233645          DOI: 10.1016/j.rmed.2011.07.012

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  29 in total

Review 1.  Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality.

Authors:  Don D Sin; S F Paul Man
Journal:  Proc Am Thorac Soc       Date:  2005

2.  Lung volume reduction surgery improves maximal O2 consumption, maximal minute ventilation, O2 pulse, and dead space-to-tidal volume ratio during leg cycle ergometry.

Authors:  J O Benditt; S Lewis; D E Wood; L Klima; R K Albert
Journal:  Am J Respir Crit Care Med       Date:  1997-08       Impact factor: 21.405

3.  Lung-volume reduction improves dyspnea, dynamic hyperinflation, and respiratory muscle function.

Authors:  F J Martinez; M M de Oca; R I Whyte; J Stetz; S E Gay; B R Celli
Journal:  Am J Respir Crit Care Med       Date:  1997-06       Impact factor: 21.405

4.  Cause of the raised wedge pressure on exercise in chronic obstructive pulmonary disease.

Authors:  J Butler; F Schrijen; A Henriquez; J M Polu; R K Albert
Journal:  Am Rev Respir Dis       Date:  1988-08

5.  Stability of improvements in exercise performance and quality of life following bilateral lung volume reduction surgery in severe COPD.

Authors:  F Cordova; G O'Brien; S Furukawa; A M Kuzma; J Travaline; G J Criner
Journal:  Chest       Date:  1997-10       Impact factor: 9.410

6.  Hemodynamics of patients with severe chronic obstructive pulmonary disease during progressive upright exercise.

Authors:  R W Light; H M Mintz; G S Linden; S E Brown
Journal:  Am Rev Respir Dis       Date:  1984-09

7.  Changes in breathing and ventilatory muscle recruitment patterns induced by lung volume reduction surgery.

Authors:  J O Benditt; D E Wood; F D McCool; S Lewis; R K Albert
Journal:  Am J Respir Crit Care Med       Date:  1997-01       Impact factor: 21.405

8.  Respiratory muscle and cardiopulmonary function during exercise in very severe COPD.

Authors:  M Montes de Oca; J Rassulo; B R Celli
Journal:  Am J Respir Crit Care Med       Date:  1996-11       Impact factor: 21.405

9.  A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema.

Authors:  Alfred Fishman; Fernando Martinez; Keith Naunheim; Steven Piantadosi; Robert Wise; Andrew Ries; Gail Weinmann; Douglas E Wood
Journal:  N Engl J Med       Date:  2003-05-20       Impact factor: 91.245

10.  Effects of lung volume reduction surgery on left ventricular diastolic filling and dimensions in patients with severe emphysema.

Authors:  Kirsten Jörgensen; Erik Houltz; Ulla Westfelt; Folke Nilsson; Henrik Scherstén; Sven-Erik Ricksten
Journal:  Chest       Date:  2003-11       Impact factor: 9.410

View more
  15 in total

1.  CT scan-measured pulmonary artery to aorta ratio and echocardiography for detecting pulmonary hypertension in severe COPD.

Authors:  Anand S Iyer; J Michael Wells; Sonia Vishin; Surya P Bhatt; Keith M Wille; Mark T Dransfield
Journal:  Chest       Date:  2014-04       Impact factor: 9.410

2.  Cor pulmonale parvus in chronic obstructive pulmonary disease and emphysema: the MESA COPD study.

Authors:  Steven M Kawut; Hooman D Poor; Megha A Parikh; Katja Hueper; Benjamin M Smith; David A Bluemke; João A C Lima; Martin R Prince; Eric A Hoffman; John H M Austin; Jens Vogel-Claussen; R Graham Barr
Journal:  J Am Coll Cardiol       Date:  2014-11-03       Impact factor: 24.094

3.  Impact Of Peak Oxygen Pulse On Patients With Chronic Obstructive Pulmonary Disease.

Authors:  Chih-Wei Wu; Po-Chun Hsieh; Mei-Chen Yang; I-Shiang Tzeng; Yao-Kuang Wu; Chou-Chin Lan
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-11-20

4.  Percent Emphysema and Daily Motor Activity Levels in the General Population: Multi-Ethnic Study of Atherosclerosis.

Authors:  Christian M Lo Cascio; Mirja Quante; Eric A Hoffman; Alain G Bertoni; Carrie P Aaron; Joseph E Schwartz; Mark V Avdalovic; Vincent S Fan; Gina S Lovasi; Steven M Kawut; John H M Austin; Susan Redline; R Graham Barr
Journal:  Chest       Date:  2016-12-06       Impact factor: 9.410

5.  Endobronchial Coils Versus Lung Volume Reduction Surgery or Medical Therapy for Treatment of Advanced Homogenous Emphysema.

Authors:  Nathaniel Marchetti; Theresa Kaufman; Divay Chandra; Felix J Herth; Pallav L Shah; Dirk-Jan Slebos; Chandra Dass; Stephen Bicknell; Stefan H Blaas; Michael Pfeifer; Franz Stanzell; Christian Witt; Gaetan Deslee; Wolfgang Gesierich; Martin Hetzel; Romain Kessler; Sylvie Leroy; Juergen Hetzel; Frank C Sciurba; Gerard J Criner
Journal:  Chronic Obstr Pulm Dis       Date:  2018-04-01

6.  Morphologic Response of the Pulmonary Vasculature to Endoscopic Lung Volume Reduction.

Authors:  Farbod N Rahaghi; Carolyn E Come; James Ross; Rola Harmouche; Alejandro A Diaz; Raul San Jose Estepar; George Washko
Journal:  Chronic Obstr Pulm Dis       Date:  2015

7.  Cardiovascular and respiratory dysfunction in chronic obstructive pulmonary disease complicated by impaired peripheral oxygenation.

Authors:  Ming-Lung Chuang; Shih-Feng Huang; Chun-Hung Su
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-02-11

8.  Learning from the Cardiologists and Developing Eluting Stents Targeting the Mtor Pathway for Pulmonary Application; A Future Concept for Tracheal Stenosis.

Authors:  Paul Zarogoulidis; Kaid Darwiche; Kosmas Tsakiridis; Helmut Teschler; Lonny Yarmus; Konstantinos Zarogoulidis; Lutz Freitag
Journal:  J Mol Genet Med       Date:  2013-08-26

9.  Lung Deflation and Cardiovascular Structure and Function in Chronic Obstructive Pulmonary Disease. A Randomized Controlled Trial.

Authors:  Ian S Stone; Neil C Barnes; Wai-Yee James; Dawn Midwinter; Redha Boubertakh; Richard Follows; Leonette John; Steffen E Petersen
Journal:  Am J Respir Crit Care Med       Date:  2016-04-01       Impact factor: 21.405

Review 10.  Cardiovascular function in pulmonary emphysema.

Authors:  Dina Visca; Marina Aiello; Alfredo Chetta
Journal:  Biomed Res Int       Date:  2013-12-03       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.